Balboa Wealth Partners’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
2,324
-81
-3% -$11.4K 0.05% 320
2026
Q1
$315K Sell
2,405
-30
-1% -$4.31K 0.05% 296
2025
Q4
$323K Sell
2,435
-212
-8% -$28.1K 0.05% 274
2025
Q3
$347K Buy
2,647
+12
+0.5% +$1.64K 0.06% 248
2025
Q2
$351K Buy
2,635
+483
+22% +$55.4K 0.07% 218
2025
Q1
$236K Sell
2,152
-243
-10% -$29.3K 0.06% 235
2024
Q4
$297K Sell
2,395
-31
-1% -$3.76K 0.07% 211
2024
Q3
$265K Sell
2,426
-648
-21% -$69.7K 0.07% 201
2024
Q2
$339K Buy
3,074
+477
+18% +$52.7K 0.09% 174
2024
Q1
$295K Sell
2,597
-29
-1% -$2.98K 0.09% 169
2023
Q4
$256K Sell
2,626
-411
-14% -$37.6K 0.08% 184
2023
Q3
$293K Sell
3,037
-162
-5% -$15.4K 0.11% 160
2023
Q2
$289K Buy
+3,199
New +$269K 0.1% 168
2023
Q1
Sell
-2,748
Closed -$264K 306
2022
Q4
$264K Buy
+2,748
New +$247K 0.12% 174

Other funds holding EMR

Balboa Wealth Partners's EMR Position: Q2 2026 in Review

Balboa Wealth Partners reduced its Emerson Electric (EMR) stake by 3.4% in Q2 2026, selling an estimated $11.4K and leaving 2,324 shares worth $333K. The position accounts for 0.05% of the portfolio, ranked #320.

Balboa Wealth Partners first reported a position in EMR in Q4 2022 and has held it in 14 quarters since. The position peaked at $351K in Q2 2025. 2,284 funds tracked by Wall St. Rank hold EMR as of Q2 2026.

  • Balboa Wealth Partners held 2,324 shares of Emerson Electric worth $333K as of Q2 2026.
  • Balboa Wealth Partners sold 81 Emerson Electric shares in Q2 2026, an estimated $11.4K.
  • Emerson Electric made up 0.05% of Balboa Wealth Partners's portfolio in Q2 2026, its #320 holding.
  • Balboa Wealth Partners first reported a position in Emerson Electric in Q4 2022 and has held it in 14 quarters since.
  • Balboa Wealth Partners's Emerson Electric position peaked at $351K in Q2 2025.
  • 2,284 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.